SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $668,050,000 | -32.2% | 15,500 | -50.8% | 0.14% | -28.2% |
| Q1 2017 | $985,950,000 | +13.2% | 31,500 | -8.7% | 0.19% | +11.9% |
| Q4 2016 | $871,125,000 | -0.8% | 34,500 | -2.8% | 0.17% | +9.8% |
| Q3 2016 | $877,915,000 | +807.3% | 35,500 | +647.4% | 0.15% | +800.0% |
| Q2 2016 | $96,758,000 | +33.6% | 4,750 | 0.0% | 0.02% | +30.8% |
| Q1 2016 | $72,438,000 | -61.6% | 4,750 | -66.2% | 0.01% | -59.4% |
| Q4 2015 | $188,832,000 | -20.1% | 14,050 | -16.6% | 0.03% | +3.2% |
| Q3 2015 | $236,406,000 | – | 16,850 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |